Latest News

DNA ‘barcode’ delivering personalised breast cancer care

Scientists in Cambridge say advances in genetics are set to transform the treatment of breast cancer, making it more personalised to each patient. All women there diagnosed with breast cancer have their entire genetic code mapped. Doctors say it is helping them chose the right treatment and predict whether patients are likely to experience side effects. It […]

Read More

OncoCheckpoint: Companion DX for Cdc7 inhibitors

Oncologica has established the first comprehensive predictive test for Cdc7 inhibitors using its state of the art Next Generation Sequencing platform validated for the delivery of Oncologica’s precision oncology clinical services. Our newly developed Cdc7 companion Dx “OncoCheckpoint” analyses the major signalling components of the DNA replication origin activation checkpoint for all activating/inactivating genetic aberrations that […]

Read More

AML and chemotherapy. A study recently co-authored by Oncologica

The ability to assess which patients with acute myeloid leukemia (AML) will derive benefit from chemotherapy is a challenge using current technologies. Oncologica has recently co-authored a study in which we show that analysis of the proliferative state of leukemic tumour cells exploiting the evolutionary conserved proteins that replicate a cell’s DNA can be used […]

Read More


Here at Happy Magazine we try to focus on all things positive for the cancer journey. This can be anything from a tasty recipe to a motivational video or a great new product which we think might be helpful. We try to steer clear of any heavy medical information as we feel that there is […]

Read More

Revolutionary test can tailor the best therapy for cancer patients

A revolutionary new test, which takes the “guesswork” out of deciding what treatment will be most effective for a cancer patient, has been launched in Ireland. Dr David Fennelly, oncologist at St Vincent’s Hospital in Dublin, said the Oncofocus test has great potential to improve the survival of cancer patients. This will include not just […]

Read More

Oncofocus Cancer Test and targeted therapies. The Revolution in cancer treatment has begun.

Chemotherapy is no longer the only option against cancer, there are now more than 600 targeted therapies available to treat solid tumours. Targeted therapies are the cornerstone of personalized medicine, a form of medicine that uses information about a person’s DNA profile to treat cancer.  The Oncofocus test can identify new treatment options in 85% of […]

Read More

UK chief medical officer calls for gene testing revolution within five years. But the revolution is actually already here.

In 5 years cancer patients should be routinely offered DNA tests to help select the best treatments for them, according to Prof Dame Sally Davies, England’s chief medical officer. But cancer does not wait and “the Revolution” is actually already here. Since 2015 Oncologica indeed offers to the wide public at an accessible cost Oncofocus […]

Read More

Every cancer patient could have DNA tested under five-year government plan to cut deaths

Future goal is for every cancer patient to have his or her whole genome sequenced A new era of genome-based personalised medicine could open up for cancer patients within five years under new plans unveiled by the Government’s chief medical adviser. The “genomics dream” outlined by Professor Dame Sally Davies would see millions of patients […]

Read More

Chemotherapy is no longer the only option against cancer…

Chemotherapy is no longer the only option against cancer, there are now more than 600 targeted therapies available to treat solid tumors.  Targeted cancer therapies are new drugs that kill cancer cells but do not affect normal cells compared with chemotherapy which kills both cancer cells and normal cells. Targeted therapies are the cornerstone of […]

Read More

Dr. Hussein Tawbi, melanoma

Two combination therapies shrink melanoma brain metastases in more than half of patients

High response rates to a pair of combination therapies point to potentially new options for a group of metastatic melanoma patients who have been largely left out of recent treatment progress – those whose disease has spread to the brain. A combination regimen of two immunotherapies and another of two targeted therapies each significantly shrank […]

Read More


Oncologica Ltd. to open lab in Dublin

Oncologica, a cutting-edge precision cancer testing company is planning to open a laboratory in Dublin. Co-founded by Cambridge-based professor Gareth Williams and Dr Marco Loddo, the company is already working with the leading oncologist Dr David Fennelly who is a consultant at St Vincent’s Hospital and the Blackrock Clinic, as well as general practitioner Dr […]

Read More

terminal cancer

Dad with terminal cancer given hope by ground-breaking precision oncology test

A father of two with terminal cancer has been given new hope after being offered a free pioneering test to help find alternative treatments. Mick Weldon, 38, from Cambourne, has a rare form of stomach cancer which is resistant to conventional forms of treatment. In April, the News reported on Mick’s efforts to crowdfund enough […]

Read More